<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00260</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (i) Body weight and brain region weights at time of sacrifice for each subject tested;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (ii) Indication of whether each subject survived to sacrifice or time of death;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (iii) Data from control animals and blank samples; and  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (iv) Statistical evaluation of results;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (2)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Evaluation of Results.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (i) Results shall be evaluated in terms of the extent of change in the amount of GFAP as a function of treatment and dose. GFAP assays (of any brain region) from a minimum of 6 samples typically will result in a standard error of the mean of +/^ 5 percent. In this case, a chemically-induced increase in GFAP of 115 percent of control is likely to be statistically significant.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (ii) The results of this assay shall be compared to and evaluated with any relevant behavioral and histopathological data.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (e)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> References.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> For additional background information on this test guideline the following references should be consulted.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=26 g=1 f=1 --> (1) Brock, T.O and O'Callaghan, J.P. 1987. Quantitative changes in the synaptic vesicle proteins, synapsin I and p38 and the astrocyte specific protein, glial fibrillary acidic protein, are associated with chemical-induced injury to the rat central nervous system, J. Neurosci. 7:931&hyph;942.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (2) Jahn, R., Schiebler, W. Greengard, P. 1984. A quantitative dot-immunobinding assay for protein using nitrocellulose membrane filters. Proc. Natl. Acad. Sci. U.S.A. 81:1684&hyph;1687.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (3) O'Callaghan, J.P. 1988. Neurotypic and gliotypic protein as biochemical markers of neurotoxicity. Neurotoxicol. Teratol. 10:445&hyph;452.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (4) O'Callaghan, J.P. 1991. Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol. Teratol. 13:275&hyph;281.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (5) O'Callaghan, J.P. and Miller, D.B. 1985. Cerebellar hypoplasia in the Gunn rat is associated with quantitative changes in neurotypic and gliotypic proteins. J. Pharmacol. Exp. Ther. 234:522&hyph;532.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (6) Sette, W.F. ``Pesticide Assessment Guidelines, Subdivision `F', Hazard Evaluation: Human and Domestic Animals, Addendum 10, Neurotoxicity, Series 81, 82, and 83'' US-EPA, Office of Pesticide Programs, EPA&hyph;540/09&hyph;91&hyph;123, March 1991.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (7) Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J., Klenk, D.C. 1985. Measurement of protein using bicinchoninic acid. Annal. Biochem. 150:76&hyph;85.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;79.68 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Salmonella typhimurium reverse mutation assay.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Purpose.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Salmonella typhimurium  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> histidine (his) reversion system is a microbial assay which measures his <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> ^ <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=7 f=3 --> c <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  his <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> + <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  reversion induced by chemicals which cause base changes or frameshift mutations in the genome of the microorganism  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Salmonella typhimurium.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (b) Definitions.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> For the purposes of this section, the following definitions apply:  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=15 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=15 g=1 f=3 --> Base pair mutagen  <!-- PJG /ITAG -->  <!-- PJG ITAG l=15 g=1 f=1 --> means an agent which causes a base change in DNA. In a reversion assay, this change may occur at the site of the original mutation or at a second site in the chromosome.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=15 g=1 f=3 --> Frameshift mutagen  <!-- PJG /ITAG -->  <!-- PJG ITAG l=15 g=1 f=1 --> is an agent which causes the addition or deletion of single or multiple base pairs in the DNA molecule.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=15 g=1 f=3 --> Salmonella typhimurium reverse mutation assay  <!-- PJG /ITAG -->  <!-- PJG ITAG l=15 g=1 f=1 --> detects mutation in a gene of a histidine-requiring strain to produce a histidine independent strain of this organism.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            